Daily Baricitinib Treatment Preserves β-Cell Function in Type 1 Diabetes
THURSDAY, Dec. 7, 2023 (HealthDay News) — Daily baricitinib treatment over 48 weeks...
Read MoreDec 8, 2023
THURSDAY, Dec. 7, 2023 (HealthDay News) — Daily baricitinib treatment over 48 weeks...
Read MoreDec 8, 2023
THURSDAY, Dec. 7, 2023 (HealthDay News) — Patients who present with breast cancer with...
Read MoreDec 8, 2023
THURSDAY, Dec. 7, 2023 (HealthDay News) — Among patients with hormone receptor-positive...
Read MoreDec 8, 2023
THURSDAY, Dec. 7, 2023 (HealthDay News) — In a push for lower drug prices, the Biden...
Read MoreDec 8, 2023
THURSDAY, Dec. 7, 2023 (HealthDay News) — From 2016 to 2022, there was a decrease in the...
Read More